Leaderboards/Antibiotic Use and Resistance

Antibiotic Use and Resistance

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Hatim Sati
World Health Organization
2
Samuel Ajulo
Texas Tech University
3
Pramod Barathe
Savitribai Phule Pune University
4
Amna Abbas
Population Health Research Institute
5
Alejandro Acosta
Food and Agriculture Organization of the United Nations
6
Sijo Asokan
Mahatma Gandhi University
7
Mabel Budia-Silva
University of Freiburg
8
Lilly Josephine Bindel
Medizinische Hochschule Hannover
9
Wuraola Akande‐Sholabi
University of Ibadan
10
Joseph Fanous
University of Basel

Papers

1
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
The Lancet Infectious Diseases|2025
560 cit.
2
Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries
PLoS ONE|2024
226 cit.
3
Antibiotic pollution and associated antimicrobial resistance in the environment
Journal of Hazardous Materials Letters|2024
222 cit.
4
Antibiotic resistance: A key microbial survival mechanism that threatens public health
Cell Host & Microbe|2024
181 cit.
5
International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe
Nature Communications|2024
118 cit.
6
The future of antibiotic use in livestock
Nature Communications|2025
92 cit.
7
Klebsiella pneumoniae: A growing threat in the era of antimicrobial resistance
The Microbe|2025
61 cit.
8
Limited impact of Salmonella stress and persisters on antibiotic clearance
Nature|2025
51 cit.
9
Publication in Next research. (2025) [14 citations, W4412643803]
Next research.|2025
14 cit.
10
Publication in Phytomedicine Plus (2025) [10 citations, W4414439609]
Phytomedicine Plus|2025
10 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Timo Smieszek
Public Health England
2
Verónica Rico
Hospital Clínic de Barcelona
3
Diane Ashiru‐Oredope
University of Nottingham
4
Baoli Zhu
Chinese Preventive Medicine Association
5
Carlos Narciso‐da‐Rocha
Universidade Católica Portuguesa
6
Sumanth Gandra
Center for Disease Dynamics, Economics & Policy
7
Talene A. Metjian
Children's Hospital of Philadelphia
8
Jeroen Schouten
Radboud University Nijmegen
9
Katherine E. Fleming-Dutra
Centers for Disease Control and Prevention
10
Nataliya L. Blatt
Kazan Federal University

Papers

1
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR Morbidity and Mortality Weekly Report|2023
279 cit.
2
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
MMWR Morbidity and Mortality Weekly Report|2024
167 cit.
3
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
JAMA|2022
161 cit.
4
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
MMWR Morbidity and Mortality Weekly Report|2023
149 cit.
5
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
MMWR Morbidity and Mortality Weekly Report|2022
72 cit.
6
Assessment of global antimicrobial resistance campaigns conducted to improve public awareness and antimicrobial use behaviours: a rapid systematic review
BMC Public Health|2024
50 cit.
7
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023
MMWR Morbidity and Mortality Weekly Report|2023
43 cit.
8
Scoping Review of National Antimicrobial Stewardship Activities in Eight African Countries and Adaptable Recommendations
Antibiotics|2022
38 cit.
9
Exploring the Antimicrobial Stewardship Educational Needs of Healthcare Students and the Potential of an Antimicrobial Prescribing App as an Educational Tool in Selected African Countries
Antibiotics|2022
30 cit.
10
Influence of factors commonly known to be associated with health inequalities on antibiotic use in high-income countries: a systematic scoping review
Journal of Antimicrobial Chemotherapy|2023
30 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Dominique L. Monnet
European Centre for Disease Prevention and Control
2
Otto Cars
Uppsala University
3
Dawn Sievert
Centers for Disease Control and Prevention
4
Ramanan Laxminarayan
Education Trust
5
Sanjay Saint
University of Michigan
6
Monique Elseviers
University of Antwerp
7
Jack D. Sobel
Wayne State University
8
Ramanan Laxminarayan
Global Antibiotic Research & Development Partnership
9
Herman Goossens
Kaneka (United States)
10
Lauri A. Hicks
Centers for Disease Control and Prevention

Papers

1
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
Clinical Microbiology and Infection|2011
14k cit.
2
Guidelines for the Prevention of Intravascular Catheter-related Infections
Clinical Infectious Diseases|2011
4.7k cit.
3
Antibiotic resistance—the need for global solutions
The Lancet Infectious Diseases|2013
4.4k cit.
4
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases|2015
4k cit.
5
Global trends in antimicrobial use in food animals
Proceedings of the National Academy of Sciences|2015
3.9k cit.
6
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Proceedings of the National Academy of Sciences|2018
3.2k cit.
7
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
The Lancet|2005
3.1k cit.
8
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
The Lancet Infectious Diseases|2014
2.3k cit.
9
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011
JAMA|2016
1.7k cit.
10
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
Infection Control and Hospital Epidemiology|2012
1.6k cit.

Reagents for Antibiotic Use and Resistance

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

PathScan® Total Axl Sandwich ELISA Kit

#7040$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 66

BCA Protein Assay Kit

#7780$410
View Evidence →
Cell Signaling TechnologyEvidence 61

AsCpf1/Cas12a (Strain BV3L6) (E1U7C) Rabbit Monoclonal Antibody

#19984$175,354
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

LIMP-2/SCARB2 (E2Z5F) Rabbit Monoclonal Antibody

Cited in 10 papers
#27960$160,351
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)

Cited in 5 papers
#37317$486
View Evidence →
Cell Signaling TechnologyEvidence 65

Acetyl-alpha-Tubulin (Lys40) (D20G3) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)

#40422$486
View Evidence →